Evidence map›Paper›PMID 31187307›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2019

Portraying infective endocarditis: results of multinational ID-IRI study.

Hakan Erdem, Edmond Puca, Yvon Ruch, Lurdes Santos, Nesrin Ghanem-Zoubi, Xavier Argemi, Yves Hansmann, Rahmet Guner, Gilda Tonziello, Jean-Philippe Mazzucotelli and 51 more

Open access · bronzeAbstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Prospective Clinical Follow-Up Results of Infective Endocarditis.Infectious diseases & clinical microbiology · 2024
    Article
  17. Article
  18. Article
  19. Perioperative Complications in Infective Endocarditis.Journal of clinical medicine · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

61 authors at 20 institutions in 14 countries.

Hakan ErdemIDI-IRI, Ankara, Turkey. hakanerdem1969@yahoo.com.ORCID http://orcid.org/0000-0002-6265-5227
Edmond PucaDepartment of Infectious Diseases, University Hospital Center "Mother Teresa", Tirana, Albania.
Yvon RuchDepartment of Infectious Diseases, Strasbourg University Hospital, Nouvel Hôpital Civil, Strasbourg, France.
Lurdes SantosInfectious Diseases Department, Centro Hospitalar São João and Faculdade de Medicina da Universidade do Porto, Porto, Portugal.
Nesrin Ghanem-ZoubiInstitute of Infectious Diseases, Rambam Health Care Campus, Haifa, Israel.
Xavier ArgemiDepartment of Infectious Diseases, Strasbourg University Hospital, Nouvel Hôpital Civil, Strasbourg, France.
Yves HansmannDepartment of Infectious Diseases, Strasbourg University Hospital, Nouvel Hôpital Civil, Strasbourg, France.
Rahmet GunerAtaturk Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Yildirim Beyazit University, Ankara, Turkey.
Gilda TonzielloClinical & Research Department for Infectious Diseases, National Institute for Infectious Diseases "Lazzaro Spallanzani", IRCCS,, Via Portuense, 292, 00149, Rome, Italy.
Jean-Philippe MazzucotelliDepartment of Cardiovascular Surgery, Strasbourg University Hospital, Nouvel Hôpital Civil, Strasbourg, France.
Najada ComoService of Infectious Disease, UHC, Tirana, Albania.
Sukran KoseDepartment of Infectious Diseases and Clinical Microbiology, Tepecik Training and Research Hospital, Izmir, Turkey.
Ayse BatirelDepartment of Infectious Diseases and Clinical Microbiology, Dr. Lutfi Kirdar Training and Research Hospital, Health Sciences University, Istanbul, Turkey.
Asuman InanDepartment of Infectious Diseases and Clinical Microbiology, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.
Necla TulekDepartment of Microbiology, Atilim University, School of Medicine, Ankara, Turkey.
Abdullah Umut PekokDepartment of Infectious Diseases and Clinical Microbiology, Pendik Medical Park Hospital, Istanbul, Turkey.
Ejaz Ahmed KhanShifa International Hospital and Shifa Tameer-e-Millat University, Islamabad, Pakistan.
Atilla IyisoyDepartment of Cardiology, Gulhane Training and Research Hospital, Health Sciences University, Ankara, Turkey.
Meliha Meric-KocDepartment of Infectious Diseases and Clinical Microbiology, Bezmialem Vakıf University School of Medicine, Istanbul, Turkey.
Ayse Kaya-KalemAtaturk Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Yildirim Beyazit University, Ankara, Turkey.
Pedro Palma MartinsInfectious Diseases Department, Centro Hospitalar São João and Faculdade de Medicina da Universidade do Porto, Porto, Portugal.
Imran HasanogluAtaturk Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Yildirim Beyazit University, Ankara, Turkey.
André Silva-PintoInfectious Diseases Department, Centro Hospitalar São João and Faculdade de Medicina da Universidade do Porto, Porto, Portugal.
Nefise OztoprakDepartment of Infectious Diseases and Clinical Microbiology, Antalya Training and Research Hospital, Health Sciences University, Antalya, Turkey.
Raquel DuroInfectious Diseases Department, Centro Hospitalar São João and Faculdade de Medicina da Universidade do Porto, Porto, Portugal.
Fahad AlmajidDepartment of Medicine, Infectious Diseases Division, King Saud University Hospital, Riyadh, Saudi Arabia.
Mustafa DoganDepartment of Infectious Diseases and Clinical Microbiology, Corlu State Hospital, Tekirdag, Antalya, Turkey.
Nicolas DaubyDepartment of Infectious Diseases, Centre Hospitalier Universitaire Saint-Pierre, Université libre de Bruxelles (ULB), 322 rue Haute, 1000, Brussels, Belgium.
Jesper Damsgaard GunstDepartment of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
Recep TekinDepartment of Infectious Diseases and Clinical Microbiology, Dicle University Faculty of Medicine, Diyarbakır, Turkey.
Deborah KonopnickiDepartment of Infectious Diseases, Centre Hospitalier Universitaire Saint-Pierre, Université libre de Bruxelles (ULB), 322 rue Haute, 1000, Brussels, Belgium.
Nicola PetrosilloClinical & Research Department for Infectious Diseases, National Institute for Infectious Diseases "Lazzaro Spallanzani", IRCCS,, Via Portuense, 292, 00149, Rome, Italy.
Ilkay BozkurtDepartment of Infectious Diseases and Clinical Microbiology, Ondokuz Mayis University School of Medicine, Samsun, Turkey.
Jamal WadiDepartment of Infectious Diseases, School of Medicine, The University of Jordan, Amman, Jordan.
Corneliu PopescuDr Victor Babes Clinical Hospital of Infectious and Tropical Disease, Bucharest, Romania.
Ilker Inanc BalkanDepartment of Infectious Diseases and Clinical Microbiology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey.
Safak Ozer-BalinDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Firat University, Elazig, Turkey.
Tatjana Lejko ZupancDepartment of Infectious Diseases, UMC Ljubljana, Ljubljana, Slovenia.
Antonio CascioDepartment of Health Promotion Sciences and Mother and Child Care "G. D'Alessandro", University of Palermo, Palermo, Italy.
Irina Magdalena DumitruClinical Infectious Diseases Hospital, Ovidius University of Constanta, Constanta, Romania.
Aysegul ErdemDepartment of Pathology, Kecioren Training and Research Hospital, Ankara, Turkey.
Gulden ErsozDepartment of Infectious Diseases and Clinical Microbiology, Mersin University School of Medicine, Mersin, Turkey.
Meltem TasbakanDepartment of Infectious Diseases and Clinical Microbiology, Ege University Faculty of Medicine, Izmir, Turkey.
Oday Abu AjamiehDepartment of Infectious Diseases, School of Medicine, The University of Jordan, Amman, Jordan.
Fatma SirmatelDepartment of Infectious Disease and Clinical Microbiology, Izzet Baysal University School of Medicine, Bolu, Turkey.
Simin FlorescuDr Victor Babes Clinical Hospital of Infectious and Tropical Disease, Bucharest, Romania.
Serda GulsunDepartment of Infectious Diseases and Clinical Microbiology, Diyarbakir Training and Research Hospital, Diyarbakir, Turkey.
Hacer Deniz OzkayaDepartment of Infectious Diseases and Clinical Microbiology, Cigli Regional Education Hospital, Izmir, Turkey.
Sema SariDepartment of Intensive Care Unit, Turkey Advanced Specialty Education and Research Hospital, Ankara, Turkey.
Selma TosunDepartment of Infectious Diseases and Clinical Microbiology, Izmir Bozyaka Training and Research Hospital, Izmir, Turkey.
Meltem AvciDepartment of Infectious Disease and Clinical Microbiology, Usak University School of Medicine, Usak, Turkey.
Yasemin CagDepartment of Infectious Diseases and Clinical Microbiology, Medeniyet University, Goztepe Training and Research Hospital, Istanbul, Turkey.
Guven CelebiDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Bulent Ecevit University, Zonguldak, Turkey.
Ayse Sagmak-TartarDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Firat University, Elazig, Turkey.
Sumeyra KarakusDepartment of Infectious Diseases and Clinical Microbiology, Medeniyet University, Goztepe Training and Research Hospital, Istanbul, Turkey.
Alper SenerDepartment of Infectious Diseases and Clinical Microbiology, Onsekiz Mart University School of Medicine, Canakkale, Turkey.
Arjeta DedejDepartment of Nephrology, American Hospital, Tirana, Albania.
Serkan OncuDepartment of Infectious Diseases and Clinical Microbiology, Adnan Menderes University School of Medicine, Aydin, Turkey.
Rosa Fontana Del VecchioDepartment of Clinical and Molecular Biomedicine, Section of Infectious Diseases, University of Catania, Catania, Italy.
Derya Ozturk-EnginDepartment of Infectious Diseases and Clinical Microbiology, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey.
Canan AgalarDepartment of Infectious Diseases and Clinical Microbiology, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey.
Hôpital Civil, Strasbourg · FRUniversidade do Porto · PTAnkara Yıldırım Beyazıt University · TRSağlık Bilimleri Üniversitesi · TRCentre Hospitalier Universitaire de Saint-Pierre · BEFatih Sultan Mehmet Eğitim Ve Araştırma Hastanesi · TRFırat University · TRIstanbul Medeniyet University · TRIstituto Nazionale per le Malattie Infettive Lazzaro Spallanzani · ITSpitalul Clinic Dr. Victor Babes · ROUniversity of Jordan · JOAarhus University Hospital · DKAdnan Menderes University · TRAtilim University · TRBezmiâlem Vakıf Üniversitesi · TRBolu Abant İzzet Baysal University · TRBülent Ecevit University · TRÇanakkale Onsekiz Mart Üniversitesi · TRDicle University · TRDiyarbakır Askeri Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infective endocarditis is a growing problem with many shifts due to ever-increasing comorbid illnesses, invasive procedures, and increase in the elderly. We performed this multinational study to depict definite infective endocarditis. Adult patients with definite endocarditis hospitalized between January 1, 2015, and October 1, 2018, were included from 41 hospitals in 13 countries. We included microbiological features, types and severity of the disease, complications, but excluded therapeutic parameters. A total of 867 patients were included. A total of 631 (72.8%) patients had native valve endocarditis (NVE), 214 (24.7%) patients had prosthetic valve endocarditis (PVE), 21 (2.4%) patients had pacemaker lead endocarditis, and 1 patient had catheter port endocarditis. Eighteen percent of NVE patients were hospital-acquired. PVE patients were classified as early-onset in 24.9%. A total of 385 (44.4%) patients had major embolic events, most frequently to the brain (n = 227, 26.3%). Blood cultures yielded pathogens in 766 (88.4%). In 101 (11.6%) patients, blood cultures were negative. Molecular testing of vegetations disclosed pathogens in 65 cases. Overall, 795 (91.7%) endocarditis patients had any identified pathogen. Leading pathogens (Staphylococcus aureus (n = 267, 33.6%), Streptococcus viridans (n = 149, 18.7%), enterococci (n = 128, 16.1%), coagulase-negative staphylococci (n = 92, 11.6%)) displayed substantial resistance profiles. A total of 132 (15.2%) patients had cardiac abscesses; 693 (79.9%) patients had left-sided endocarditis. Aortic (n = 394, 45.4%) and mitral valves (n = 369, 42.5%) were most frequently involved. Mortality was more common in PVE than NVE (NVE (n = 101, 16%), PVE (n = 49, 22.9%), p = 0.042).

Indexed as

AdolescentAdultAgedAged, 80 and overAortic ValveBacteriaEndocarditisEndocarditis, BacterialFemaleHospital MortalityHumansInternationalityMaleMiddle AgedMitral ValveProsthesis-Related InfectionsBlood cultureInfective endocarditisNativeProstheticS. aureus

Identifiers

PMID31187307
OpenAlexW2950295913

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.